Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
---|
06/22/2006 | US20060135578 Five-membered heterocyclic compounds |
06/22/2006 | US20060135576 2-Amino-(imidazole, thiazole, or oxazole) derivatives; tyrosine kinase, endothelial growth factor, angiogenesis and fibroblast growth factor inhibitors; anticarcinogenic and antidiabetic agents |
06/22/2006 | US20060135573 Benzothiazole-4,7-diones and benzoxazole-4,7-diones with substituents in position 5 or 6 and method for production thereof |
06/22/2006 | US20060135568 Methods of treating microbial infections in humans and animals |
06/22/2006 | CA2589678A1 Novel mch receptor antagonists |
06/22/2006 | CA2589495A1 2-arylpropionic acid derivatives and pharmaceutical compositions containing them |
06/21/2006 | EP1671956A1 Mixture of Oxazolines and its use as processing aid for polymers and pigments |
06/21/2006 | EP1670773A1 Methods for the preparation of benzoxazole sulfonamide compounds and intermediates thereof |
06/21/2006 | EP1670772A1 Derivatives of 1,3-diones having a herbicidal activity |
06/21/2006 | EP1208092B1 Sulfonamide derivative as a matrix metalloproteinase inhibitor |
06/21/2006 | CN1791409A (3-{3-' (2,4-bis- trifluormethyl -benzyl)-(5 -ethyl-pyrimidin -2-yl)- amino! -propoxy} -phenyl) -acetic acid and related compounds as modulators of ppars and methods of treating metabolic disorders |
06/21/2006 | CN1789267A Method for synthesizing tricyclic compound |
06/21/2006 | CN1260222C Antagonists of mcp-1 function and methods of use thereof |
06/20/2006 | US7064123 substituted acetamides; uses for treating diseases including arthritis, muscular dystrophy, inflammation, tumor invasion, glomerulonephritis, malaria, periodontal disease, and metachromatic leukodystrophy |
06/20/2006 | CA2135480C Trisubstituted phenyl derivatives as phosphodiesterase inhibitors and processes for their preparation |
06/15/2006 | WO2006061378A1 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
06/15/2006 | WO2006061377A1 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
06/15/2006 | WO2006061376A1 Aryloxyethylamine derivatives with a combination of partial d0pamine-d2 receptor agonism and serotonin reuptake inhibition |
06/15/2006 | WO2006061193A1 Indenyl derivatives and use thereof for the treatment of neurological disorders |
06/15/2006 | WO2006061135A1 Phenyl-piperazin methanone derivatives |
06/15/2006 | US20060128737 Androgen receptor agonists |
06/15/2006 | US20060128703 crystalline linezolid form III (N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide) an antibacterial agent; thermal stability |
06/15/2006 | US20060124017 New compounds, a process for their preparation and their use as dyes and pigments |
06/15/2006 | CA2589831A1 Indenyl derivatives and use thereof for the treatment of neurological disorders |
06/15/2006 | CA2589192A1 Phenyl-piperazin methanone derivatives |
06/15/2006 | CA2587559A1 Aryloxyethylamine derivatives with a combination of partial d0pamine-d2 receptor agonism and serotonin reuptake inhibition |
06/15/2006 | CA2587357A1 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
06/15/2006 | CA2587202A1 Phenylpiperazine derivatives with a combination of partial dopamine-d2 receptor agonism and serotonin reuptake inhibition |
06/14/2006 | EP1669070A2 2-imino-thiazolidine and -oxazolidine derivatives for use as antiinflammatory agents |
06/14/2006 | EP1667957A2 Amino acids with affinity for the alpha2delta-protein |
06/14/2006 | EP1667955A2 Cycloalkylidene compounds as modulators of the estrogen receptor |
06/14/2006 | EP1324989B1 5-trityloxymethyl-2-oxazolidinone and process for the preparation thereof |
06/14/2006 | CN1259312C Compound of substituted benzo heterocyclic by electrophosphorescence |
06/13/2006 | US7060720 Compounds useful for treating or preventing IMPDH associated disorders, such as transplant rejection and autoimmune diseases and inhibitors of inosine-5'-monophosphate dehydrogenase). The compounds and pharmaceutical compositions |
06/13/2006 | CA2387997C Process for preparing oxazolines from tetrahydrofurans |
06/08/2006 | WO2006058905A1 5-CARBOXAMIDO SUBSTITUTED THIAZOLE DERIVATIVES THAT INTERACT WITH ION CHANNELS, IN PARTICULAR WITH ION CHANNELS FROM THE Kv FAMILY |
06/08/2006 | WO2006028972A3 Mercaptoamides as histone deacetylase inhibitors |
06/08/2006 | WO2005107464A3 Compounds and compositions as cathepsin s inhibitors |
06/08/2006 | US20060122245 Novel inhibitors of IMPDH enzyme |
06/08/2006 | US20060122242 2-Aryloxy-2-arylalkanoic acids for diabetes and lipid disorders |
06/08/2006 | US20060122239 Lipid diseases; metabolism diosrders; antiproliferative agents |
06/08/2006 | US20060122231 Such as N-(4-tert-butylphenyl)-4-(2-pyridinyl)benzamide for treatment of urinary incontinence, pain, inflammatory thermal hyperalgesia, and/or bladder overactivity |
06/08/2006 | US20060122181 Heteroaromatic pentacyclic compound and medicinal use thereof |
06/08/2006 | CA2588517A1 5-carboxamido substituted thiazole derivatives that interact with ion channels, in particular with ion channels from the kv family |
06/08/2006 | CA2586334A1 Compounds for the treatment of cns and amyloid associated diseases |
06/07/2006 | EP1664039A1 1,3-benzoxazolyl derivatives as kinase-inhibitors |
06/07/2006 | EP1664006A2 Modulators of atp-binding cassette transporters |
06/07/2006 | EP1664003A1 Haloalkyl containing compounds as cysteine protease inhibitors |
06/07/2006 | EP1664002A1 Organic compounds |
06/07/2006 | EP1664001A2 Biaryl heterocyclic amines, amides, and sulfur-containing compounds and methods of making and using the same |
06/07/2006 | EP1663962A2 Compositions and methods for the treatment of disease associated with trp-p8 expression |
06/07/2006 | EP1663953A1 Inhibitors of histone deacetylase |
06/07/2006 | EP1663234A1 Piperazine derivatives for the treatment of hiv infections |
06/07/2006 | EP1585725A4 Compounds which mimic the chemical and biological properties of discodermolide |
06/07/2006 | CN1784438A Azlactone chain transfer agents for free radical polymerization |
06/07/2006 | CN1781915A Method for producing an oxazolylethanol derivative |
06/07/2006 | CN1781914A Organic polymer and novel polymerizable compound |
06/06/2006 | US7057066 Process for producing 3-amino-2-hydroxypropionic acid derivatives |
06/06/2006 | US7057038 Kinetic resolutions of chiral 2- and 3-substituted carboxylic acids |
06/06/2006 | US7057037 P-bis(4-(oxo)-4H-3,1-benzazin-2-yl)benzene having a melt beginning temperature and/or a weight loss beginning temperature obtained under a specified condition adjusted within a specified range; heat resistance; transparent |
06/06/2006 | US7056932 Heterocyclyl substituted 1-alkoxy acetic acid amides |
06/06/2006 | US7056903 Administering a therapeutical carbamate derivative to a patient as prostaglandin IP (12 or PGI2) antagonists |
06/06/2006 | CA2352592C Quinazolinone compounds |
06/06/2006 | CA2215066C Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors |
06/01/2006 | WO2006030211A3 Acyclic sulphonamides |
06/01/2006 | WO2005040139A8 2-Aminoaryloxazole compounds as tyrosine kinase inhibitors |
06/01/2006 | US20060116377 Dialkylhydroxybenzoic acid derivatives containing metal chelating groups and their therapeutic uses |
06/01/2006 | DE10308350B4 Verfahren zur Herstellung der enantiomeren Formen von cis-konfigurierten 1,3-Cyclohexandiol-Derivaten A process for preparing the enantiomeric forms of cis-configured 1,3-cyclohexanediol derivatives |
06/01/2006 | CA2588607A1 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production |
05/31/2006 | EP1661890A1 Ppar-activating compound and pharmaceutical composition containing same |
05/31/2006 | EP1661879A1 Diphenyl ether compound, process for producing the same, and use |
05/31/2006 | EP1661564A1 Heterocyclic compounds and their pharmaceutical use |
05/31/2006 | EP1660492A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
05/31/2006 | EP1660491A1 Benzimidazole, benzthiazole and benzoxazole derivatives and their use as lta4h modulators |
05/31/2006 | EP1660489A1 Intermediate products for producing oxazolidinone-quinolone hybrids |
05/31/2006 | EP1660488A1 Novel antimicrobial aryloxazolidinone compounds |
05/31/2006 | EP1660466A1 Method of obtaining urethane-protected n-carboxyanhydrides of alpha amino acids |
05/31/2006 | EP1660465A2 Process for the synthesis of biaryl oxazolidinones |
05/31/2006 | EP1660449A1 Aminopropanol derivatives |
05/31/2006 | EP1660428A1 Ppar modulators |
05/31/2006 | EP1660427A1 Substituted arylalkanoic acid derivative and use thereof |
05/31/2006 | EP1392295B1 Carboxylic acid substituted oxazole derivatives for use as ppar-alpha and -gamma activators in the treatment of diabetes |
05/31/2006 | EP1343772B1 Thia- and oxazoles and their use as ppars activators |
05/31/2006 | CN1780823A Heteroaromatic pentacyclic compound and medicinal use thereof |
05/30/2006 | US7053234 Antibacterial agents |
05/30/2006 | US7053222 Semi-synthetic process for the preparation of N-debenzoylpaclitaxel |
05/30/2006 | US7053111 Autoimmune disease; organ transplanting; controlling cell proliferation, cell differentiation |
05/30/2006 | US7053110 Dietetics; osteoporosis; muscular disorders |
05/30/2006 | US7053109 Aminediols for the treatment of Alzheimer's disease |
05/30/2006 | US7053106 Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
05/30/2006 | US7053088 Vanilloid receptor ligands and their use in treatments |
05/26/2006 | WO2006055837A2 Process for preparing oxazolidine derivatives |
05/26/2006 | WO2006055184A2 Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms) |
05/26/2006 | WO2006054102A1 Microcin b17 analogs and methods for their preparation and use |
05/26/2006 | WO2006045088A3 Polymer-filler coupling additives |
05/26/2006 | WO2006026316A3 Prodrug substituted benzoxazoles as estrogenic agents |
05/26/2006 | CA2587678A1 Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms) |
05/26/2006 | CA2587224A1 Microcin b17 analogs and methods for their preparation and use |
05/25/2006 | US20060111408 Therapeutic benzothiazole compounds |
05/25/2006 | US20060111359 enzyme inhibitor for treating sleep disorders |